Sign in
CompletedNo phase

Menopause Age and Anxiety-Depression

Key facts

Who runs it
Ankara City Hospital Bilkent
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
136 people enrolled
Started
15 Dec 2024
Ended
15 Sept 2025
Type of study
Observational, 2 groups
Treatments tested
  • Beck Anxıety Inventory (BAI)
  • State-Trait Anxiety Scale (STAI) 1-2
Record updated
19 December 2025

Who can take part

Age
24 years and older
Sex
Women only
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Healthy women over 24 years of age who visited our hospital for routine outpatient check-ups, had been diagnosed with menopause, and had no history of psychiatric disorders before menopause

Who cannot take part

  • Cardiovascular diseases including hypertension
  • Type 1 or type 2 diabetes mellitus
  • Primary adrenal insufficiency
  • Thyroid dysfunctions including Hashimoto thyroiditis and Grave's disease
  • Renal insufficiency
  • Genetic disorders in chromosome constitution or karyotype analysis including monosomy X, trisomy X and gene mutations as BMP15, FMR I, POFIB, and GDF9
  • Neurologic diseases
  • Psychiatric disorders
  • Autoimmune diseases or syndromes including Addison's disease, autoimmune syndromes, scleroderma, Sjogren's syndrome, myasthenia gravis, inflammatory bowel diseases, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus and familial Mediterranean fever
  • History of any malignancy
  • History of exposure to chemotherapeutic agents or radiotherapy
  • Individuals with a history of chronic or regular medication use that could cause anxiety or depression symptoms
  • Individuals with a personal history of psychiatric disorders
  • Individuals with a history of depression in the past 6 months
  • Morbid obesity
  • Uterine fibroids
  • Hepatic dysfunctions

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Menopause is defined as the permanent cessation of menstrual cycles due to ovarian follicle depletion, typically occurring after age 50, and is associated with decreased estrogen levels. Primary ovarian insufficiency (POI) involves early ovarian dysfunction before age 40, with infertility as a key concern. Both menopause and POI may contribute to psychological symptoms, including anxiety and depression, influenced by sociodemographic and health factors. While literature reports anxiety in middle-aged women, data on its association with menopausal timing are limited. This study aims to compare women with POI and those undergoing natural menopause after age 40, assessing the relationship between age at menopause, anxiety, and depression, as well as the impact of fertility expectations on psychological well-being in POI patients.

The 2 groups in the trial

  • Menopause group

    Patients over 40 years of age who have undergone menopause and who visited our hospital's obstetrics and gynecology outpatient clinic for routine check-ups, without any additional diseases or complaints.

    Treatment: Beck Anxıety Inventory (BAI) and State-Trait Anxiety Scale (STAI) 1-2

  • Primary ovarian insufficiency (POI) group

    Patients who experienced menopause before the age of 40 and who visited our hospital's obstetrics and gynecology outpatient clinic for routine check-ups, without any additional diseases or complaints.

    Treatment: Beck Anxıety Inventory (BAI) and State-Trait Anxiety Scale (STAI) 1-2

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Association Between Age at Menopause and Levels of Anxiety and Depression
Record updated
19 December 2025